Derrick J. Rossi
Fondateur chez Stelexis Therapeutics LLC
Profil
Derrick J.
Rossi is the founder of ModernaTX, Inc. (founded in 2011), Intellia Therapeutics, Inc. (founded in 2014), Magenta Therapeutics, Inc. (founded in 2015), Moderna, Inc. (founded in 2010), and Stelexis Therapeutics LLC (founded in 2017) where he holds the title of Director.
Currently, Dr. Rossi is the Chief Executive Officer & Director at New York Stem Cell Foundation, Inc. (since 2010), President, Chief Executive Officer & Director at Convelo Therapeutics, Inc., and Director at Ophirex, Inc. Dr. Rossi obtained his undergraduate and graduate degrees from the University of Toronto and a doctorate degree from the University of Helsinki in 2003.
Postes actifs de Derrick J. Rossi
| Sociétés | Poste | Début |
|---|---|---|
Stelexis Therapeutics LLC
 Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Fondateur | 01/01/2017 |
Convelo Therapeutics, Inc.
 Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | Directeur Général | - |
| New York Stem Cell Foundation, Inc. | Directeur Général | - |
Ophirex, Inc.
 Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Derrick J. Rossi
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Fondateur | - |
| INTELLIA THERAPEUTICS, INC. | Fondateur | - |
| MAGENTA THERAPEUTICS | Fondateur | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Fondateur | - |
Formation de Derrick J. Rossi
| University of Toronto | Graduate Degree |
| University of Helsinki | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| New York Stem Cell Foundation, Inc. | Miscellaneous |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Convelo Therapeutics, Inc.
Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | Health Technology |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Health Technology |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Commercial Services |
